Genetic Variation in Estrogen Sulfation Genes and Endometrial Cancer Risk
Genetic Variation in Estrogen Sulfation Genes and Endometrial Cancer Risk
批准号:
7652296
负责人:
VERONICA WENDY SETIAWAN
金额:
$8.15万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-01 至 2012-07-31
关键词:
AccountingAfrican AmericanAllelesAutomobile DrivingCaliforniaCandidate Disease GeneCell ProliferationCohort StudiesDatabasesDevelopmentDiseaseEndometrial CarcinomaEndometriumEnvironmental Risk FactorEnzymesEstrogensEstrone sulfotransferaseEvaluationExposure toGenesGeneticGenetic PolymorphismGenetic Predisposition to DiseaseGenetic VariationGenomicsGlucuronosyltransferaseHandHawaiian populationHigh Risk WomanHormonesHydrolysisIndividualInorganic SulfatesJapanese AmericanLatinoLeadLinkage DisequilibriumMalignant NeoplasmsMediatingMetabolic BiotransformationMethodsNested Case-Control StudyObesityPathway interactionsPlayPostmenopausePredispositionProductionProgesteroneProphylactic treatmentPublic HealthRegulationRiskRisk FactorsRoleSingle Nucleotide PolymorphismTechnologyTransferaseUGT1A1 geneUnderserved PopulationUnspecified or Sulfate Ion SulfatesUridine DiphosphateVariantWomananalytical methodcancer riskcarcinogenesiscohortdisorder riskestrogen sulfataseestrogen sulfategenotyping technologyhigh riskhormone therapynovelpopulation basedprospectivereceptorsulfationteacher
中文摘要
描述(由申请人提供):这项申请背后的一个驱动前提是子宫内膜癌与过度暴露于非拮抗雌激素密切相关。雌激素驱动细胞增殖,因此为随机遗传错误的积累提供了机会,这些错误可能导致子宫内膜癌的进展。硫酸盐偶联在雌激素的生物转化中起着重要的作用。雌激素硫转移酶催化生物活性雌激素向无活性雌激素硫酸盐的转化,从而将这些激素从受体介导和导致致癌的遗传毒性途径中“转移”出来。另一方面,雌激素硫酸酯酶将生物上无活性的硫酸雌激素水解为活性雌激素。葡萄糖醛酸化,由udp -葡萄糖醛酸转移酶催化,是雌激素代谢成无活性化合物的另一途径。这些酶在子宫内膜中表达,在调节局部雌激素产生中起重要作用。我们假设调节雌激素结合的基因的功能多态性与子宫内膜癌风险相关。尚未对这些基因中与子宫内膜癌风险相关的常见遗传变异进行全面评估。在本应用程序中,我们将在两个大型前瞻性队列中进行两项病例对照研究,研究SULT1A1、SULT1E1、STS和UGT1A1中假定的功能多态性和标记单核苷酸多态性(snp)与子宫内膜癌风险之间的关系,以及基因和基因环境与确定的子宫内膜癌风险因素之间的相互作用。多种族队列(500例和1000例对照)和加州教师研究(400例和800例对照)。通过结合这些研究,我们将能够交叉验证和复制具有启发性的发现,并具有足够的统计能力来检测与常见等位基因相关的适度影响,并探索基因与基因环境的相互作用。在这里,我们将利用新的高通量多路基因分型技术来评估许多snp,并应用严格的统计分析方法来解释多重比较问题。最后,我们的队列是独一无二的,因为它们提供了一个机会来研究美国多种族和有时服务不足人群中子宫内膜癌遗传易感性和环境风险因素的变化。疾病等位基因的发现将具有重要的公共卫生意义,因为它有助于确定高危妇女,她们将从预防措施中获益最多。
英文摘要
DESCRIPTION (provided by applicant): A driving premise behind this application is that endometrial cancer is strongly related to excessive exposure to unopposed estrogens. Estrogens drive cell proliferation, and thus the opportunity for the accumulation of random genetic errors that can lead to progression of endometrial cancer. Sulfate conjugation plays an important role in the biotransformation of estrogens. Estrogen sulfotransferases catalyze the conversion of biologically active estrogens to inactive estrogen sulfates, thereby "diverting" these hormones from both receptor mediated and genotoxic pathways leading to carcinogenesis. Estrogen sulfatases, on the other hand, hydrolyze biologically inactive estrogen-sulfate to active estrogens. Glucuronidation, catalyzed by UDP-glucuronosyl transferase enzymes, is another pathway through which estrogens can be metabolized to inactive compounds. These enzymes are expressed in the endometrium and play an important role in the regulation of local estrogenic production. We hypothesize that functional polymorphisms in genes regulating estrogen conjugation are associated with endometrial cancer risk. A comprehensive evaluation of common genetic variation in these genes in relation to endometrial cancer risk has not been conducted. In this application, we will examine associations between putative functional polymorphisms and tagging single nucleotide polymorphisms (SNPs) in SULT1A1, SULT1E1, STS and UGT1A1 with endometrial cancer risk, along with genexgene and genexenvironment interactions with established endometrial cancer risk factors, in two case-control studies nested within two large prospective cohorts: the Multiethnic Cohort (500 cases and 1,000 controls) and the California Teachers Study (400 cases and 800 controls). By combining these studies we will be able to cross-validate and replicate suggestive findings, and have an adequate statistical power to detect modest effects associated with common alleles and to explore genexgene and genexenvironment interactions. Here we will utilize novel high-throughput multiplexing genotyping technology for evaluating many SNPs and apply a rigorous statistical analytic method to account for multiple comparison issue. Finally, our cohorts are unique because they provide an opportunity to study variations in genetic susceptibility to endometrial cancer and environmental risk factors in multiethnic and sometimes underserved populations in the U.S. The discovery of disease alleles would have an important public health implication as it helps identify high-risk women who would benefit the most from prevention measures.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Advanced NAFLD Disparities in Hispanics: A Multi-level Analysis
-
批准号:10530687
-
项目类别:
-
资助金额:$61.5万
-
财政年份:2021
-
负责人:VERONICA WENDY SETIAWAN
-
依托单位:
Mechanisms of Advanced NAFLD Disparities in Hispanics: A Multi-level Analysis
-
批准号:10323053
-
项目类别:
-
资助金额:$68.39万
-
财政年份:2021
-
负责人:VERONICA WENDY SETIAWAN
-
依托单位:
Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer
-
批准号:10541824
-
项目类别:
-
资助金额:$44.03万
-
财政年份:2019
-
负责人:VERONICA WENDY SETIAWAN
-
依托单位:
Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer
-
批准号:10321615
-
项目类别:
-
资助金额:$60.98万
-
财政年份:2019
-
负责人:VERONICA WENDY SETIAWAN
-
依托单位:
Understanding the Determinants of Racial/Ethnic Disparities in Liver Cancer and Chronic Liver Disease in Understudied and High-Risk Populations
-
批准号:10112841
-
项目类别:
-
资助金额:$35.03万
-
财政年份:2018
-
负责人:VERONICA WENDY SETIAWAN
-
依托单位:
Contribution of Racial Disparity Towards the Early Development of Pancreatic Cancer
-
批准号:10006120
-
项目类别:
-
资助金额:$3.35万
-
财政年份:2018
-
负责人:VERONICA WENDY SETIAWAN
-
依托单位:
Investigating the cause of racial/ethnic disparity in pancreatic cancer incidence
-
批准号:9300756
-
项目类别:
-
资助金额:$39.51万
-
财政年份:2017
-
负责人:VERONICA WENDY SETIAWAN
-
依托单位:
Investigating the cause of racial/ethnic disparity in hepatocellular cancer risk
-
批准号:8829805
-
项目类别:
-
资助金额:$8.24万
-
财政年份:2014
-
负责人:VERONICA WENDY SETIAWAN
-
依托单位:
Investigating the cause of racial/ethnic disparity in hepatocellular cancer risk
-
批准号:8704088
-
项目类别:
-
资助金额:$8.22万
-
财政年份:2014
-
负责人:VERONICA WENDY SETIAWAN
-
依托单位:
Type 1 and Type 2 Endometrial Cancer: Have They Different Risk Factors? A Pooled
-
批准号:7659200
-
项目类别:
-
资助金额:$8.15万
-
财政年份:2009
-
负责人:VERONICA WENDY SETIAWAN
-
依托单位:
Type 1 and Type 2 Endometrial Cancer: Have They Different Risk Factors? A Pooled
-
批准号:7779484
-
项目类别:
-
资助金额:$8.11万
-
财政年份:2009
-
负责人:VERONICA WENDY SETIAWAN
-
依托单位:
Genetic Variation in Estrogen Sulfation Genes and Endometrial Cancer Risk
-
批准号:7522621
-
项目类别:
-
资助金额:$8.15万
-
财政年份:2008
-
负责人:VERONICA WENDY SETIAWAN
-
依托单位:
Genes, Hormones and Breast Cancer Risk
-
批准号:7194556
-
项目类别:
-
资助金额:$12.16万
-
财政年份:2006
-
负责人:VERONICA WENDY SETIAWAN
-
依托单位:
Genes, Hormones and Breast Cancer Risk
-
批准号:7918112
-
项目类别:
-
资助金额:$13.08万
-
财政年份:2006
-
负责人:VERONICA WENDY SETIAWAN
-
依托单位:
Genes, Hormones and Breast Cancer Risk
-
批准号:7486312
-
项目类别:
-
资助金额:$12.79万
-
财政年份:2006
-
负责人:VERONICA WENDY SETIAWAN
-
依托单位:
Genes, Hormones and Breast Cancer Risk
-
批准号:7679136
-
项目类别:
-
资助金额:$13.17万
-
财政年份:2006
-
负责人:VERONICA WENDY SETIAWAN
-
依托单位:
Genes, Hormones and Breast Cancer Risk
-
批准号:7287823
-
项目类别:
-
资助金额:$12.03万
-
财政年份:2006
-
负责人:VERONICA WENDY SETIAWAN
-
依托单位:
Cancer Epidemiology
-
批准号:10620147
-
项目类别:
-
资助金额:$8.14万
-
财政年份:1996
-
负责人:VERONICA WENDY SETIAWAN
-
依托单位:
Cancer Epidemiology
-
批准号:10332403
-
项目类别:
-
资助金额:$8.21万
-
财政年份:1996
-
负责人:VERONICA WENDY SETIAWAN
-
依托单位:
Contribution of Racial Disparity Towards the Early Development of Pancreatic Cancer
-
批准号:9788331
-
项目类别:
-
资助金额:$3.25万
-
财政年份:--
-
负责人:VERONICA WENDY SETIAWAN
-
依托单位:
海外基金